drugset / Trial / NCT02939430

Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding

NCT02939430

Unknown 40 enrolled Mansoura University
RandomizedParallel-groupDouble-blindDiagnostic

Summary

Sugammadex is new drug that is used for reversal of rocuronium induced muscle relaxation. benefits of reversal of neuromuscular blockade appears to be of great value in living donor liver transplant recipients. However, Few Clinical reports have investigated the anticoagulant effect of sugammadex. In this study, effects of sugammadex on bleeding profile of living donor liver transplantation will be investigated.

Timeline

Start
2016-11
Primary completion
2017-10
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 40 ug/kg Intravenous
Comparator Neostigmine Other / unclassified 80 ug/kg Intravenous
Subject Sugammadex Other / unclassified 2 mg/kg Intravenous

Indications

No indication recorded.